| Ann & Robert H Lurie Childrens Hospital Of Chicago | |
| 225 E Chicago Ave, Box 140, Chicago, Illinois 60611 | |
| (312) 227-4000 | |
| Not Available |
| Name | Ann & Robert H Lurie Childrens Hospital Of Chicago |
|---|---|
| Type | Childrens Hospital |
| Location | 225 E Chicago Ave, Box 140, Chicago, Illinois |
| Ownership | Voluntary non-profit - Private |
| Emergency Services | Yes |
| Medicare ID (CCN) | 143300 |
| NPI Number | 1497018154 |
| Organization Name | ANN AND ROBERT H LURIE CHILDRENS HOSPITAL OF CHICAGO |
| Address | 225 E Chicago Ave, Chicago, IL 60611 |
| Hospital Type | Chronic Disease Hospital - Children |
| Phone Number | 312-227-4000 |
News Archive
BioMedReports.Com, the news portal which covers Wall Street's biomedical sector and delivers financial and investment intelligence to a community of highly informed investors, has published an exclusive interview with the CEO of Novelos Therapeutics, Inc., Harry S. Palmin.
Sanofi and Regeneron Pharmaceuticals, Inc. today announced that the Phase 3 ODYSSEY MONO trial with alirocumab, an investigational monoclonal antibody targeting PCSK9 (proprotein convertase subtilisin/kexin type 9), met its primary efficacy endpoint.
Helicos BioSciences Corporation (NASDAQ: HLCS) announced today its operating highlights for the quarter ended June 30, 2009 and other recent developments following the filing of its Quarterly Report on Form 10-Q for the period ended June 30, 2009.
Industry led, The Better Health at Work Alliance (BHWA) will bring together a broad range of leading organisations and individual experts to collaborate in offering their knowledge and insight.
› Verified 7 days ago
| NPI Number | 1538279518 |
| Organization Name | ANN & ROBERT H LURIE CHILDRENS HOSPITAL OF CHICAGO |
| Address | 225 E Chicago Ave, #44, Chicago, IL 60611 |
| Hospital Type | General Acute Care Hospital - Children |
| Phone Number | 312-573-4581 |
News Archive
BioMedReports.Com, the news portal which covers Wall Street's biomedical sector and delivers financial and investment intelligence to a community of highly informed investors, has published an exclusive interview with the CEO of Novelos Therapeutics, Inc., Harry S. Palmin.
Sanofi and Regeneron Pharmaceuticals, Inc. today announced that the Phase 3 ODYSSEY MONO trial with alirocumab, an investigational monoclonal antibody targeting PCSK9 (proprotein convertase subtilisin/kexin type 9), met its primary efficacy endpoint.
Helicos BioSciences Corporation (NASDAQ: HLCS) announced today its operating highlights for the quarter ended June 30, 2009 and other recent developments following the filing of its Quarterly Report on Form 10-Q for the period ended June 30, 2009.
Industry led, The Better Health at Work Alliance (BHWA) will bring together a broad range of leading organisations and individual experts to collaborate in offering their knowledge and insight.
› Verified 7 days ago
| NPI Number | 1780789081 |
| Organization Name | ANN & ROBERT H. LURIE CHILDRENS HOSPITAL OF CHICAGO |
| Address | 225 E Chicago Ave, Box 44, Chicago, IL 60611 |
| Hospital Type | General Acute Care Hospital - Children |
| Phone Number | 312-227-7118 |
News Archive
BioMedReports.Com, the news portal which covers Wall Street's biomedical sector and delivers financial and investment intelligence to a community of highly informed investors, has published an exclusive interview with the CEO of Novelos Therapeutics, Inc., Harry S. Palmin.
Sanofi and Regeneron Pharmaceuticals, Inc. today announced that the Phase 3 ODYSSEY MONO trial with alirocumab, an investigational monoclonal antibody targeting PCSK9 (proprotein convertase subtilisin/kexin type 9), met its primary efficacy endpoint.
Helicos BioSciences Corporation (NASDAQ: HLCS) announced today its operating highlights for the quarter ended June 30, 2009 and other recent developments following the filing of its Quarterly Report on Form 10-Q for the period ended June 30, 2009.
Industry led, The Better Health at Work Alliance (BHWA) will bring together a broad range of leading organisations and individual experts to collaborate in offering their knowledge and insight.
› Verified 7 days ago
| NPI Number | 1861837718 |
| Organization Name | ANN AND ROBERT H. LURIE CHILDREN'S HOSPITAL |
| Address | 225 East Chicago Ave, Chicago, IL 60611 |
| Hospital Type | General Acute Care Hospital - Children |
| Phone Number | 312-227-4000 |
News Archive
BioMedReports.Com, the news portal which covers Wall Street's biomedical sector and delivers financial and investment intelligence to a community of highly informed investors, has published an exclusive interview with the CEO of Novelos Therapeutics, Inc., Harry S. Palmin.
Sanofi and Regeneron Pharmaceuticals, Inc. today announced that the Phase 3 ODYSSEY MONO trial with alirocumab, an investigational monoclonal antibody targeting PCSK9 (proprotein convertase subtilisin/kexin type 9), met its primary efficacy endpoint.
Helicos BioSciences Corporation (NASDAQ: HLCS) announced today its operating highlights for the quarter ended June 30, 2009 and other recent developments following the filing of its Quarterly Report on Form 10-Q for the period ended June 30, 2009.
Industry led, The Better Health at Work Alliance (BHWA) will bring together a broad range of leading organisations and individual experts to collaborate in offering their knowledge and insight.
› Verified 7 days ago
| NPI Number | 1871698175 |
| Organization Name | ANN & ROBERT H. LURIE CHILDRENS HOSPITAL OF CHICAGO |
| Address | 225 E Chicago Ave, Box 44, Chicago, IL 60611 |
| Hospital Type | General Acute Care Hospital - Children |
| Phone Number | 312-227-7118 |
News Archive
BioMedReports.Com, the news portal which covers Wall Street's biomedical sector and delivers financial and investment intelligence to a community of highly informed investors, has published an exclusive interview with the CEO of Novelos Therapeutics, Inc., Harry S. Palmin.
Sanofi and Regeneron Pharmaceuticals, Inc. today announced that the Phase 3 ODYSSEY MONO trial with alirocumab, an investigational monoclonal antibody targeting PCSK9 (proprotein convertase subtilisin/kexin type 9), met its primary efficacy endpoint.
Helicos BioSciences Corporation (NASDAQ: HLCS) announced today its operating highlights for the quarter ended June 30, 2009 and other recent developments following the filing of its Quarterly Report on Form 10-Q for the period ended June 30, 2009.
Industry led, The Better Health at Work Alliance (BHWA) will bring together a broad range of leading organisations and individual experts to collaborate in offering their knowledge and insight.
› Verified 7 days ago
| NPI Number | 1962507269 |
| Organization Name | ANN & ROBERT H. LURIE CHILDREN'S HOSPTIAL OF CHICAGO |
| Address | 225 E Chicago Ave, Box 44, Chicago, IL 60611 |
| Hospital Type | General Acute Care Hospital - Children |
| Phone Number | 312-227-7118 |
News Archive
BioMedReports.Com, the news portal which covers Wall Street's biomedical sector and delivers financial and investment intelligence to a community of highly informed investors, has published an exclusive interview with the CEO of Novelos Therapeutics, Inc., Harry S. Palmin.
Sanofi and Regeneron Pharmaceuticals, Inc. today announced that the Phase 3 ODYSSEY MONO trial with alirocumab, an investigational monoclonal antibody targeting PCSK9 (proprotein convertase subtilisin/kexin type 9), met its primary efficacy endpoint.
Helicos BioSciences Corporation (NASDAQ: HLCS) announced today its operating highlights for the quarter ended June 30, 2009 and other recent developments following the filing of its Quarterly Report on Form 10-Q for the period ended June 30, 2009.
Industry led, The Better Health at Work Alliance (BHWA) will bring together a broad range of leading organisations and individual experts to collaborate in offering their knowledge and insight.
› Verified 7 days ago
| Able to receive lab results electronically | Not Available |
| Able to track patients' lab results, tests, and referrals electronically between visits | Not Available |
News Archive
BioMedReports.Com, the news portal which covers Wall Street's biomedical sector and delivers financial and investment intelligence to a community of highly informed investors, has published an exclusive interview with the CEO of Novelos Therapeutics, Inc., Harry S. Palmin.
Sanofi and Regeneron Pharmaceuticals, Inc. today announced that the Phase 3 ODYSSEY MONO trial with alirocumab, an investigational monoclonal antibody targeting PCSK9 (proprotein convertase subtilisin/kexin type 9), met its primary efficacy endpoint.
Helicos BioSciences Corporation (NASDAQ: HLCS) announced today its operating highlights for the quarter ended June 30, 2009 and other recent developments following the filing of its Quarterly Report on Form 10-Q for the period ended June 30, 2009.
Industry led, The Better Health at Work Alliance (BHWA) will bring together a broad range of leading organisations and individual experts to collaborate in offering their knowledge and insight.
› Verified 7 days ago
Mt Sinai Hospital Medical Center Acute Care Hospital Location: 15th Street At California, Chicago, Illinois 60608 Phone: (773) 542-2000 | |
Advocate Trinity Hospital Acute Care Hospital Location: 2320 E 93rd St, Chicago, Illinois 60617 Phone: (773) 967-5002 | |
Roseland Community Hospital Acute Care Hospital Location: 45 W 111th Street, Chicago, Illinois 60628 Phone: (773) 995-3000 | |
Louis A Weiss Memorial Hospital Acute Care Hospital Location: 4646 N Marine Drive, Chicago, Illinois 60640 Phone: (773) 878-8700 | |
Loretto Hospital Acute Care Hospital Location: 645 South Central Ave, Chicago, Illinois 60644 Phone: (773) 626-4300 | |
The University Of Chicago Medical Center Acute Care Hospital Location: 5841 South Maryland, Chicago, Illinois 60637 Phone: (773) 702-1000 |